Ultra-low-dose anti-VEGF treatment in retinopathy of prematurity

Eur J Ophthalmol. 2022 Jan;32(1):NP290. doi: 10.1177/1120672119868428. Epub 2019 Aug 5.

Authors

Alparslan Şahin¹, Muhammed Şahin², Fatih Mehmet Türkcü³

Affiliations

¹ Department of Ophthalmology, Zilan Private Hospital, Batman, Turkey.
² Department of Ophthalmology, School of Medicine, Dicle University, Diyarbakır, Turkey.
³ Department of Ophthalmology, Bower Private Hospital, Diyarbakır, Turkey.

PMID: 31378076
DOI: 10.1177/1120672119868428

No abstract available

MeSH terms

Angiogenesis Inhibitors / therapeutic use
Bevacizumab / therapeutic use
Humans
Infant, Newborn
Intravitreal Injections
Retinopathy of Prematurity* / drug therapy

Substances

Angiogenesis Inhibitors
Bevacizumab